{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:51:04Z","timestamp":1789984264301,"version":"4.0.1"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.cld.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T17:18:38Z","timestamp":1508001518000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis"],"prefix":"10.1016","volume":"22","author":[{"given":"Zobair M.","family":"Younossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alita","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2017.08.001_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases","author":"Chalasani","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2017.08.001_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.cld.2017.08.001_bib3","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.4254\/wjh.v7.i13.1788","article-title":"Non-alcohol fatty liver disease in Asia: prevention and planning","volume":"7","author":"Ashtari","year":"2015","journal-title":"World J Hepatol"},{"issue":"11","key":"10.1016\/j.cld.2017.08.001_bib4","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1007\/s10620-015-3728-3","article-title":"Prevalence of nonalcoholic fatty liver disease and economy","volume":"60","author":"Zhu","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.cld.2017.08.001_bib5","first-page":"105","article-title":"Comparative analyses of genetic risk prediction methods reveal extreme diversity of genetic predisposition to nonalcoholic fatty liver disease (NAFLD) among ethnic populations of India","volume":"94","author":"Chatterjee","year":"2015","journal-title":"J\u00a0Genet"},{"issue":"1","key":"10.1016\/j.cld.2017.08.001_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States the third national health and nutrition examination survey, 1988-1994","volume":"178","author":"Lazo","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cld.2017.08.001_bib7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2017.08.001_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/oby.20426","article-title":"Racial differences in nonalcoholic fatty liver disease in the U.S. population","volume":"22","author":"Schneider","year":"2014","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.cld.2017.08.001_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cgh.2015.05.001","article-title":"Nonalcoholic fatty liver disease in Latinos","volume":"14","author":"Saab","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2017.08.001_bib10","article-title":"Acculturation and NAFLD risk among Hispanics of Mexican-origin: findings from the National Health and Nutrition Examination Survey","author":"Balakrishnan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2017.08.001_bib11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/oby.2009.4","article-title":"Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort","volume":"17","author":"Wagenknecht","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.cld.2017.08.001_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cld.2015.10.005","article-title":"The prevalence and pathobiology of nonalcoholic fatty liver disease in patients of different races or ethnicities","volume":"20","author":"Kalia","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2017.08.001_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","article-title":"Gender and racial differences in nonalcoholic fatty liver disease","volume":"6","author":"Pan","year":"2014","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2017.08.001_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ajg.2008.12","article-title":"The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients","volume":"104","author":"Kallwitz","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2017.08.001_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cgh.2015.08.010","article-title":"Trends in the burden of nonalcoholic fatty liver disease in a United States cohort of veterans","volume":"14","author":"Kanwal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2017.08.001_bib16","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/oby.2008.657","article-title":"Impact of race\/ethnicity on the relationship between visceral fat and inflammatory biomarkers","volume":"17","author":"Carroll","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"10.1016\/j.cld.2017.08.001_bib17","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/ijo.2014.25","article-title":"Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort","volume":"38","author":"Morimoto","year":"2014","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"10.1016\/j.cld.2017.08.001_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/jgh.12106","article-title":"Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups","volume":"28","author":"Smits","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2017.08.001_bib19","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/hep.24726","article-title":"Nonalcoholic steatohepatitis clinical research network research group ethnicity and nonalcoholic fatty liver disease","volume":"55","author":"Bambha","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2017.08.001_bib20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s11695-010-0078-2","article-title":"Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease","volume":"20","author":"Stepanova","year":"2010","journal-title":"Obes Surg"},{"issue":"5","key":"10.1016\/j.cld.2017.08.001_bib21","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/jgh.12856","article-title":"Anti-adipocyte antibody response in patients with non-alcoholic fatty liver disease","volume":"30","author":"Karrar","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2017.08.001_bib22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/liv.12555","article-title":"Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD","volume":"35","author":"Estep","year":"2015","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.cld.2017.08.001_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.metabol.2012.02.005","article-title":"Race-ethnic differences in adipokine levels: the study of Women's Health across the Nation (SWAN)","volume":"61","author":"Khan","year":"2012","journal-title":"Metabolism"},{"issue":"17","key":"10.1016\/j.cld.2017.08.001_bib24","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.3748\/wjg.v20.i17.4987","article-title":"NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis","volume":"20","author":"Fleischman","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2017.08.001_bib25","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s10620-013-2652-7","article-title":"The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA)","volume":"58","author":"Foster","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2017.08.001_bib26","doi-asserted-by":"crossref","first-page":"460190","DOI":"10.1155\/2015\/460190","article-title":"Genetic factors in the pathogenesis of nonalcoholic fatty liver and steatohepatitis","volume":"2015","author":"Dongiovanni","year":"2015","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.cld.2017.08.001_bib27","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2017.08.001_bib28","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/hep.26986","article-title":"Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S","volume":"59","author":"Wong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2017.08.001_bib29","doi-asserted-by":"crossref","first-page":"450639","DOI":"10.1155\/2013\/450639","article-title":"Nonalcoholic fatty liver disease, diabetes mellitus and cardiovascular disease: newer data","volume":"2013","author":"Mavrogiannaki","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.cld.2017.08.001_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9\u00b71 million participants","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cld.2017.08.001_bib31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2017.08.001_bib32","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.2174\/1381612811319290003","article-title":"Disease - atherosclerosis as a major player in the natural course of NAFLD","volume":"19","author":"Lonardo","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.cld.2017.08.001_bib33","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.cld.2017.08.001_bib34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.cld.2017.08.001_bib35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.cld.2017.08.001_bib36","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.cld.2017.08.001_bib37","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2017.08.001_bib38","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2017.08.001_bib39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.cld.2017.08.001_bib40","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/ijc.25797","article-title":"Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis","volume":"128","author":"Ertle","year":"2011","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.cld.2017.08.001_bib41","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1007\/s10620-015-3821-7","article-title":"Hepatocellular carcinoma in the setting of non-cirrhotic nonalcoholic fatty liver disease and the metabolic syndrome: US experience","volume":"60","author":"Perumpail","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"5","key":"10.1016\/j.cld.2017.08.001_bib42","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1159\/000438473","article-title":"Non-alcoholic steatohepatitis-related hepatocellular carcinoma: a growing epidemic?","volume":"33","author":"Yopp","year":"2015","journal-title":"Dig Dis"},{"key":"10.1016\/j.cld.2017.08.001_bib43","series-title":"GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11","author":"Ferlay","year":"2013"},{"issue":"3","key":"10.1016\/j.cld.2017.08.001_bib44","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cgh.2014.08.013","article-title":"Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population","volume":"13","author":"Mittal","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2017.08.001_bib45","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","article-title":"Nonalcoholic fatty liver disease in patients with type 2 diabetes","volume":"2","author":"Younossi","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2017.08.001_bib46","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s10620-012-2446-3","article-title":"Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease","volume":"58","author":"Otgonsuren","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.cld.2017.08.001_bib47","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cgh.2011.12.039","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2017.08.001_bib48","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2017.08.001_bib49","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2017.08.001_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clinre.2016.07.005","article-title":"Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases","volume":"41","author":"Motamed","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2017.08.001_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gutjnl-2016-311854","article-title":"Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study","volume":"66","author":"Sinn","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cld.2017.08.001_bib52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2017.08.001_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/17474124.2016.1099433","article-title":"Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis","volume":"10","author":"Golabi","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2017.08.001_bib54","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2017.08.001_bib55","first-page":"242","article-title":"Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"7","author":"Hashemi","year":"2016","journal-title":"Caspian J Intern Med"},{"issue":"12","key":"10.1016\/j.cld.2017.08.001_bib56","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/jgh.12665","article-title":"Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"29","author":"Otgonsuren","year":"2014","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2017.08.001_bib57","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/apt.13196","article-title":"Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study","volume":"41","author":"Cui","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2017.08.001_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1590\/1516-3180.2014.9150812","article-title":"Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)","volume":"133","author":"Goulart","year":"2015","journal-title":"Sao Paulo Med J"},{"issue":"2","key":"10.1016\/j.cld.2017.08.001_bib59","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.cld.2017.08.001_bib60","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2016.03.005","article-title":"Contribution of alcoholic and nonalcoholic fatty liver disease to the burden of liver-related morbidity and mortality","volume":"150","author":"Younossi","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2017.08.001_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/1471-230X-14-166","article-title":"Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease","volume":"14","author":"Haflidadottir","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"10.1016\/j.cld.2017.08.001_bib62","doi-asserted-by":"crossref","first-page":"e5904","DOI":"10.1097\/MD.0000000000005904","article-title":"Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities","volume":"96","author":"Golabi","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.cld.2017.08.001_bib63","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2017.08.001_bib64","doi-asserted-by":"crossref","first-page":"S598","DOI":"10.1016\/S0168-8278(17)31625-2","article-title":"Non-alcoholic steatofibrosis is independently associated with both overall mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"66","author":"Younossi","year":"2017","journal-title":"J of Hepat"},{"key":"10.1016\/j.cld.2017.08.001_bib65","doi-asserted-by":"crossref","unstructured":"Younossi Z, Stepanova M, Goodman Z, et\u00a0al. Improvement of hepatic fibrosis in patients with non-alcoholic steatohepatitis (NASH) treated with selonsertib is associated with improvement of patient-reported outcomes (PROS). [Abstract]. EASL. Amsterdam, Netherlands, April 19-23, 2017.","DOI":"10.1016\/S0168-8278(17)30368-9"},{"issue":"8","key":"10.1016\/j.cld.2017.08.001_bib66","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/liv.13391","article-title":"A\u00a0disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD","volume":"37","author":"Younossi","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2017.08.001_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12955-016-0420-z","article-title":"Non-alcoholic fatty liver disease (NAFLD) is associated with impairment of health related quality of life (HRQOL)","volume":"14","author":"Golabi","year":"2016","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"10.1016\/j.cld.2017.08.001_bib68","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s40273-015-0316-5","article-title":"Economic and quality-of-life implications of non-alcoholic fatty liver disease","volume":"33","author":"Younossi","year":"2015","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.cld.2017.08.001_bib69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/MCG.0000000000000567","article-title":"Variables associated with inpatient and outpatient resource utilization among Medicare beneficiaries with nonalcoholic fatty liver disease with or without cirrhosis","volume":"51","author":"Sayiner","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.cld.2017.08.001_bib70","doi-asserted-by":"crossref","first-page":"e004318","DOI":"10.1136\/bmjopen-2013-004318","article-title":"Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study","volume":"4","author":"Younossi","year":"2014","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.cld.2017.08.001_bib71","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326117300624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326117300624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T22:34:34Z","timestamp":1603146874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326117300624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1089326117300624"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2017.08.001","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}